A5004136681- Esophageal Cancer Research and Treatment
- Gastric Cancer Management and Outcomes
- Esophageal and GI Pathology
- Innovations in Medical Education
- Eosinophilic Esophagitis
- Gastroesophageal reflux and treatments
- Gastrointestinal Tumor Research and Treatment
- Helicobacter pylori-related gastroenterology studies
- Pancreatic and Hepatic Oncology Research
- Cancer-related gene regulation
- Tracheal and airway disorders
- Gastrointestinal disorders and treatments
- Epigenetics and DNA Methylation
- Colorectal Cancer Screening and Detection
- Metastasis and carcinoma case studies
- Lung Cancer Diagnosis and Treatment
- Neuroendocrine Tumor Research Advances
- Radiomics and Machine Learning in Medical Imaging
- Nutrition and Health in Aging
- RNA modifications and cancer
- Pancreatitis Pathology and Treatment
- Health and Wellbeing Research
- Lung Cancer Treatments and Mutations
- Cancer Genomics and Diagnostics
- Liver Disease Diagnosis and Treatment
Mayo Clinic
2016-2025
Mayo Clinic in Arizona
2016-2025
Mayo Clinic in Florida
2016-2025
WinnMed
2014-2024
University of California, Irvine
2024
Mayo Clinic Hospital
2024
Academy of Fine Arts in Katowice
2024
The Maria Sklodowska-Curie National Research Institute of Oncology
2024
Sandia National Laboratories
2023-2024
University of California, Irvine Medical Center
2024
Barrett's esophagus (BE) is among the most common conditions encountered by gastroenterologist. In this document, American College of Gastroenterology updates its guidance for best practices in caring these patients. These guidelines continue to endorse screening high-risk patients BE; however, routine limited men with reflux symptoms and multiple other risk factors. Acknowledging recent data on low malignant progression nondysplastic BE, endoscopic surveillance intervals are attenuated...
Barrett's esophagus (BE) is a common condition associated with chronic gastroesophageal reflux disease. BE the only known precursor to esophageal adenocarcinoma, highly lethal cancer an increasing incidence over last 5 decades. These revised guidelines implement Grading of Recommendations, Assessment, Development, and Evaluation methodology propose recommendations for definition diagnosis BE, screening surveillance patients medical endoscopic treatment its early neoplasia. Important changes...
We report a biomarker-based non-endoscopic method for detecting Barrett's esophagus (BE) based on methylated DNAs retrieved via swallowable balloon-based esophageal sampling device. BE is the precursor of, and major recognized risk factor for, developing adenocarcinoma. Endoscopy, current standard detection, not cost-effective population screening. performed genome-wide screening to ascertain regions targeted recurrent aberrant cytosine methylation in BE, identifying high-frequency within...
Objective The diagnosis of autoimmune pancreatitis (AIP) is challenging. Sonographic and cross-sectional imaging findings AIP closely mimic pancreatic ductal adenocarcinoma (PDAC) techniques for tissue sampling are suboptimal. These limitations often result in delayed or failed diagnosis, which negatively impact patient management outcomes. This study aimed to create an endoscopic ultrasound (EUS)-based convolutional neural network (CNN) model trained differentiate from PDAC, chronic (CP)...
The objective of this study was to compare participation rates and clinical effectiveness sedated esophagogastroduodenoscopy (sEGD) unsedated transnasal endoscopy (uTNE) for esophageal assessment Barrett's esophagus (BE) screening in a population-based cohort.This prospective, randomized, controlled trial community population. Subjects ≥50 years age who previously completed validated gastrointestinal symptom questionnaires were randomized (stratified by age, sex, reflux symptoms) one three...
Surveillance interval protocols after complete remission of intestinal metaplasia (CRIM) post radiofrequency ablation (RFA) in Barrett's oesophagus (BE) are currently empiric and not based on substantial evidence. We aimed to assess the timeline, location patterns recurrence following CRIM inform these guidelines.Data patients undergoing RFA for BE were obtained from prospectively maintained databases five (three USA two UK) tertiary referral centres. was performed until confirmed...